Joseph H. Capper net worth and biography

Joseph Capper Biography and Net Worth

Director of TELA Bio

A highly experienced and accomplished healthcare executive, Mr. Capper has nearly 30 years of experience in MedTech and Life Sciences leadership roles and a track record of substantial value creation. Mr. Capper has been CEO of MiMedx Group Inc. (NASDAQ: MDXG) since January 2023. Before that, he was CEO of BioTelemetry, Inc. (formerly NASDAQ: BEAT), from 2010 to 2021, guiding the company through a significant turn-around, which culminated in its acquisition by Royal Philips for $2.8 billion.

Prior to BioTelemetry, he served as President and CEO of both Home Diagnostics and CCS Medical. Mr. Capper brings a wealth of commercial experience, having held several leadership roles earlier in his career during the decade he spent with Bayer AG. Additionally, he was an officer in the U.S. Navy serving with distinction as a naval aviator. Mr. Capper has served on the board of directors of Anika Therapeutics, Inc. (NASDAQ: ANIK), since May 2024. Mr. Capper received his undergraduate degree in Accounting from West Chester University and an MBA in International Finance from George Washington University.

What is Joseph H. Capper's net worth?: The estimated net worth of Joseph H. Capper is at least $244.56 thousand as of September 17th, 2026. Mr. Capper owns 179,827 shares of TELA Bio stock worth more than $244,565 as of September 22nd. This net worth evaluation does not reflect any other investments that Mr. Capper may own. Learn More about Joseph H. Capper's net worth.
How do I contact Joseph H. Capper?: The corporate mailing address for Mr. Capper and other TELA Bio executives is 1 GREAT VALLEY PARKWAY SUITE 24, MALVERN PA, 19355. TELA Bio can also be reached via phone at 484-320-2930 and via email at [email protected]. Learn More on Joseph H. Capper's contact information.
Has Joseph H. Capper been buying or selling shares of TELA Bio?: During the last ninety days, Joseph H. Capper has bought $109,000.00 of TELA Bio stock. Most recently, on Thursday, September 17th, Joseph H. Capper bought 25,000 shares of TELA Bio stock. The stock was acquired at an average cost of $1.22 per share, with a total value of $30,500.00. Following the completion of the transaction, the director now directly owns 179,827 shares of the company's stock, valued at $219,388.94. Learn More on Joseph H. Capper's trading history.
Who are TELA Bio's active insiders?: TELA Bio's insider roster includes Joseph Capper (Director), and Roberto Cuca (CFO). Learn More on TELA Bio's active insiders.
Are insiders buying or selling shares of TELA Bio?: During the last year, TELA Bio insiders bought shares 5 times. They purchased a total of 3,719,000 shares worth more than $4,119,940.00. The most recent insider tranaction occured on September, 17th when Director Joseph H. Capper bought 25,000 shares worth more than $30,500.00. Insiders at TELA Bio own 1.1% of the company. Learn More about insider trades at TELA Bio.
Information on this page was last updated on 9/17/2026.

Joseph H. Capper Insider Trading History at TELA Bio

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/17/2026	Buy	25,000	$1.22	$30,500.00	179,827
9/15/2026	Buy	50,000	$1.06	$53,000.00	154,827
9/14/2026	Buy	25,000	$1.02	$25,500.00	54,827

Joseph H. Capper Buying and Selling Activity at TELA Bio

TELA Bio Company Overview

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

Today's Range

Now: $1.40

$1.28

$1.42

50 Day Range

MA: $0.80

$0.64

$1.30

2 Week Range

Now: $1.40

$0.50

$1.66

Volume

190,139 shs

Average Volume

186,981 shs

Market Capitalization

$63.02 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.36